Moreover, the results from Western blot analysis corroborated the immunohistochemical findings, both indicating a dose-dependent reduction in the expression levels of NLRP3, Caspase-1, and GSDMD in the tissues of cystitis rats post-KZMK treatment, as illustrated in Figure 12. The gene discussed is CASP1; the disease is chronic cystitis.